Synthesis · 2010 · 12 citations · 0 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryDe Novo Drug DesignEnzyme InhibitionHit-to-lead OptimizationLead Compound DesignPotency OptimizationTyrosine Kinase InhibitorsChemical Synthesis Of AnaloguesEnzyme Inhibitor DiscoveryKinase Inhibitor Library DesignKinase InhibitorsMedicinal Chemistry ApplicationsPyrazine ChemistrySmall Molecule Tyrosine Kinase Inhibitors
A potent LIMK1 inhibitor, BMS4, was synthesised in six steps starting from pyrazine-2-carboximidamide, offering a significant improvement over current methods available in the literature.